Page 39 - TD-3-3
P. 39

Tumor Discovery                                                    LncRNA HA117 in osteosarcoma regulation




                         A                                   B

















                         C                                     D




















            Figure 1. Analysis of DEGs and HA117 in osteosarcoma. (A) Volcano plot for DEGs between tumor (n = 18) and normal (n = 18) in fresh samples. (B)
            Volcano plot for DEGs between non-chemotherapy (n = 3) and chemotherapy (n = 15) in fresh tumor tissue. (C) Volcano plot displaying DEGs between
            non-chemotherapy (n = 10) and chemotherapy (n = 5) groups. (D) The expression of HA117 between different groups. The horizontal axis represents
            different groups, and the vertical axis represents log10 (FPKM+1). Numbers above each pair of bars represent the Wilcoxon test P-value. Notes: N: Normal
            group; T: Tumor group; No-ch-T: Fresh tumor samples without chemotherapy group; Ch-T: Fresh tumor samples with chemotherapy group; No-ch: FFPE
            non-chemotherapy group; Ch: FFPE chemotherapy group.
            Abbreviations: DEG: Differentially expressed gene; FPKM: Fragments per kilobase of transcript per million mapped reads.

            and  1490  down-regulated  genes  (Figure  1B).  The  most   observation indicates that these three genes may be closely
            significantly up-regulated genes were COL2A1, COL9A1,   related to the progression of osteosarcoma.
            CAPN6,  PENK, and  XIST, while the most significantly   It is worth  noting that through  edgeR analysis,
            down-regulated genes were MTRNR2L1, CNTN5, CES1,   HA117  showed  significant  down-regulation  between  the
            DAZ2, and UGT1A10 (Table S4). For FFPE samples, we
            compared 10 samples after chemotherapy (No-ch group)   chemotherapy and non-chemotherapy groups in fresh
            with five samples before chemotherapy (Ch group) (No-ch   tumor samples, as well as between the chemotherapy and
            vs. Ch groups). We found a total of 765 DEGs, including   non-chemotherapy groups in FFPE samples (FDR < 0.001,
            360  up-regulated genes and  405  down-regulated genes   Table S4). However,  there was no significant difference
            (Figure 1C). The five most significant up-regulated genes   between the tumor and normal tissues. Since edgeR uses
            were SPRR1B, SP3, LGALS8, SLC35F3, and STX7, while   the original read abundance for differential testing, to avoid
            the most significantly down-regulated genes were NFE2L2,   errors caused by a single statistical method, we subsequently
            LINC01128,  DLGAP4,  TNFRSF1A, and  CDK5RAP2.      used the Wilcoxon test to perform statistical testing on the
            From these analyses, we observed that whether in the   FPKM of HA117. The results demonstrated that compared
            comparison between tumor tissue and normal tissue or   to normal tissue in fresh samples, HA117 was down-
            in  the  comparison  of  tumor  tissue  after  chemotherapy   regulated in tumor tissue but not significantly (P > 0.05).
            and without chemotherapy, the expression of  COL2A1,   For tumor tissues from fresh samples, HA117 also showed
            COL9A1, and PENK was significantly up-regulated. This   down-regulation with chemotherapy (Figure 1D). Similar


            Volume 3 Issue 3 (2024)                         5                                 doi: 10.36922/td.3670
   34   35   36   37   38   39   40   41   42   43   44